Cost cutting, new drugs boost Amgen shares
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”27-04-2014″ enddate=”27-10-2014″ width=”300″ height=”245″] Cost cutting moves and new drugs are starting to pay off for Amgen Inc., as the biotech giant raised earnings guidance after a stronger-than-expected third quarter. The company said Oct. 27 that strong demand for its white blood cell booster, Neulasta, and increased sales of newer Read More →
Nasdaq delisting in sight for Ceres
Ceres, Inc., an agricultural biotechnology company that sells seeds for producing renewable bioenergy feedstocks, is delisting from the Nasdaq after the company continued to fail to meet the minimum bid price requirement of $1.00. The company was notified on April 28, that it no longer met the criteria for listing and in anticipation of not Read More →
Ryland shares gain on housing market performance
[wikichart align=”right” ticker=”NYSE:RYL” showannotations=”true” livequote=”true” startdate=”24-04-2014″ enddate=”24-10-2014″ width=”300″ height=”245″] Based in part on a 7.2 percent increase in third-quarter orders for new units, Westlake Village-based national homebuilder Ryland Group was trading higher Thursday after projected earnings beat Wall Street analyst expectations. Shares of Ryland Group closed at $35.78 on Oct. 23. The company reported a Read More →
Lucia aquires West Coast Asset Management office, key staff
West Coast Asset Management, the alternative investment firm founded by Paul Orfalea and family member Lance Helfert, is merging with a San Diego-based money manager.
